Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

Stick or twist? The future of HCP engagement

White Papers and Resources | June 29, 2021 | Say Communications

The Covid-19 pandemic forced companies to be more agile and rethink their value offering when engaging with HCPs, but what does the future of HCP engagement look like?

Healthcare tech: the driving force behind value-based care?

White Papers and Resources | June 29, 2021 | Avalere Health

In 2020, healthcare technology investment went into overdrive. We speak to Sunny Kumar, Partner at GSR Ventures, to find out how COVID‑19 has transformed the industry and whether healthcare technology...

Understanding the authentic patient experience can redefine the success of your clinical trial before you design it

Press Releases | June 28, 2021 | Origins – The Patient Focused Specialists

. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and...

Stick or twist? Looking at the patient experience as we emerge from the COVID pandemic

White Papers and Resources | June 28, 2021 | Say Communications

The pandemic has given us a glimpse (actually, more of a very long look) at an alternative way of receiving healthcare and engaging with the NHS. And that alternative fits...

Stick or Twist? Healthcare brands in a (post) COVID-19 world

White Papers and Resources | June 28, 2021 | Say Communications

How have our perceptions of healthcare brands and our purchasing habits changed during the COVID-19 pandemic?

Include Us All in Your Clinical Trials

Videos and Podcasts | June 25, 2021 | COUCH Health

Breaking Down the Wall: Blockchain in Healthcare and Pharma

Videos and Podcasts | June 24, 2021 | Impetus Digital

Ray Dogum, Senior Consultant and Blockchain Strategist at ConsenSys Health and Podcaster at Health Unchained, explores blockchain in Pharma and healthcare, including innovative use cases, current barriers, and how to...

Building Better Patient Advocates Through Authentic Partnerships

Videos and Podcasts | June 24, 2021 | Impetus Digital

Sabrina Hanna, Founder & CIO of the Cancer Collaborative, discusses precision medicine, innovation in oncology, how to build better patient advocates, and the current gaps when it comes to patient-centricity...

Starting a career in medical communications – experiences from the Nucleus Academy

Press Releases | June 24, 2021 | Nucleus Global

Two graduates of the Nucleus Academy training programme share their experiences of the Academy and their medical communications careers to date.

We must be candid about our use of healthcare data if we want to win back public trust

Press Releases | June 23, 2021 | Wilmington Healthcare

As the government announces a delay to a new GP data sharing initiative amid privacy concerns, Gareth Thomas, Managing Director of Wilmington Healthcare, explains why industry must move fast to...